title: Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases.
abstract: BACKGROUND
  Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood and is characterized by persistent arthritis for at least 6 weeks. Its aetiopathogenesis is unknown but there is strong evidence that there is a substantial genetic component. Chemokine receptors genes are among the candidate genes for association with arthritis and other inflammatory diseases. The CC chemokine receptor 5 (CCR5)Delta32 polymorphism has been associated with rheumatoid arthritis (RA), conferring a protective effect.
  
  
  OBJECTIVE
  To determine whether the CCR5Delta32 polymorphism is associated with JIA and RA in Brazilian patients.
  
  
  METHODS
  We investigated 203 RA patients, 101 JIA patients, and 104 healthy individuals by amplification of the CCR5Delta32 deletion. We compared the allelic frequencies among these groups, as well as among different JIA subtypes.
  
  
  RESULTS
  The frequency of the Delta32 allele was higher in JIA patients (9.4%) as compared to control subjects (3.8%) and RA patients (3.2%). Grouping the patients according to JIA subtypes, we observed a higher CCR5Delta32 allelic frequency in the subtypes with a greater inflammatory component: 4.1% in oligoarticular (n = 49), 11.2% in polyarticular (n = 40) [9.5% in rheumatoid factor negative (RF-) and 33.3% in RF positive (+)], and 25% in systemic JIA (n = 12).
  
  
  CONCLUSIONS
  This study suggests that in JIA, unlike in RA, CCR5Delta32 does not have a protective effect, but instead it could be a factor associated with more inflammatory forms of the disease. These observations give rise to new questions about the mechanism and the cellular types involved in JIA as well as about the aetiology of JIA.
authors.affiliation: Division of Rheumatology, Clinical Hospital of Porto Alegre, Brazil.
authors.forename: I
authors.initials: I
authors.lastname: Scheibel
authors.forename: T
authors.initials: T
authors.lastname: Veit
authors.forename: A G
authors.initials: AG
authors.lastname: Neves
authors.forename: L
authors.initials: L
authors.lastname: Souza
authors.forename: S
authors.initials: S
authors.lastname: Prezzi
authors.forename: S
authors.initials: S
authors.lastname: Machado
authors.forename: C
authors.initials: C
authors.lastname: Kohem
authors.forename: M
authors.initials: M
authors.lastname: Icarelli
authors.forename: R
authors.initials: R
authors.lastname: Xavier
authors.forename: J C
authors.initials: JC
authors.lastname: Brenol
authors.forename: J A B
authors.initials: JA
authors.lastname: Chies
mesh_terms: D001171:Arthritis, Juvenile / Q000235:genetics; D001172:Arthritis, Rheumatoid / Q000235:genetics*; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D005786:Gene Expression Regulation; D005787:Gene Frequency; D014644:Genetic Variation; D006801:Humans; D016133:Polymerase Chain Reaction; D019713:Receptors, CCR5 / Q000235:genetics*; D012216:Rheumatic Diseases / Q000235:genetics*; D017384:Sequence Deletion
chemical_list: D019713:Receptors, CCR5; D004247:DNA